Dr. Ken Spielvogel

So that, you know, I think again, like dosing and working with patients, it's really important that you have somebody that's clued into you.

That doses you in a way where you're not going to walk away completely.

Because I've seen clients that have done five milligrams out of the gate and are sick for two weeks.

Yeah, you can't.

So this particular client started him at 2.5.

We did that for a couple of weeks, increased him to five.

And the first thing he said was like, I'm not like all of a sudden the noise around alcohol is gone.

I'm not even thinking about it.

You know, and we'll use, you know, we have drugs for addiction that try to naltrexone.

Do you know we're the only ones doing the GLP-1s?

I mean, we've been doing it now two years.

Okay.

But there's not another treatment center that's been using these GLP-1s, not one.

I'm surprised by that.

Why?

I would think that at this point, especially with the day, I'm sure after this week where Washington Post, Women's Health, CNN, MSNBC.

No, no, no.

You don't know these people the way I do.

Let me tell you something.

The science is always 15 years ahead of the practice.